Tag archive for ‘EMA’
Gil Tanenbaum On Wednesday, January 7th, 2015

Gamida Cell Gets FDA Orphan Drug Approval

Israel’s Gamida Cell, a developer of cell therapy technologies and products for transplantation and adaptive immune therapy, announced that orphan drug designation has been granted by the FDA for its investigational More...

Gil Tanenbaum On Thursday, August 28th, 2014

Neuroderm Raises $16 Million for Parkinson’s Cure

Israel’s NeuroDerm Ltd., announced that it raised $16 million to further the clinical and regulatory development of its Levodopa products, combating Parkinson’s disease. ND0612L, NeuroDerm’s More...

Wordpress site Developed by Fixing WordPress Problems